Why the study?
Is peak postoperative hsTnT associated with 30-day mortality in patients undergoing noncardiac surgery?
Is peak postoperative hsTnT associated with 30-day mortality in patients undergoing noncardiac surgery?
Postoperative hsTnT elevation is a prognostic marker for 30-day mortality in noncardiac surgery patients, regardless of ischemic features.
Postoperative hsTnT elevation signals higher 30-day mortality risk; leaves open whether monitoring or interventions improve outcomes.
Among patients undergoing noncardiac surgery, peak postoperative hsTnT during the first 3 days after surgery was significantly associated with 30-day mortality. Elevated postoperative hsTnT without an ischemic feature was also associated with 30-day mortality.
No takes yet. Share an insight, caveat, or question.
Devereaux et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: